NAMS Technical Analysis & Stock Price Forecast

Technical Sentiment

Overall Consensus

Sell

Buy

Technical Analysis Consensus

Sell

Buy

Moving Average Consensus

Sell

Buy

NewAmsterdam Pharma Company NV (NAMS) Moving Averages Convergence Divergence (MACD) indicator is 0.728, suggesting NAMS is Neutral.

NewAmsterdam Pharma Company NV (NAMS) 20-Day simple moving average is 32.886, while NewAmsterdam Pharma Company NV (NAMS) share price is $33.82, making it Buy.

NewAmsterdam Pharma Company NV (NAMS) 60-Day simple moving average is 32.694, while NewAmsterdam Pharma Company NV (NAMS) share price is $33.82, making it Buy.

Technical Analysis for NAMS

Technical Sentiment Analysis for NewAmsterdam Pharma Company NV (NAMS) As of 2026-04-20, NewAmsterdam Pharma Company NV (NAMS) is exhibiting a Neutral technical sentiment. Our proprietary analysis, which aggregates 13 technical signals, shows that 7 indicators are flashing buy, while 6 are indicating sell.

Momentum Indicators: RSI, MACD & Overbought/Oversold Status Currently, the Relative Strength Index (RSI) for NAMS stands at 53.159, which suggests a Neutral condition. Meanwhile, the MACD (12, 26) indicator is at 0.728, providing a Buy signal for short-term momentum. Other oscillators like the Stochastic Oscillator at 62.396 and the Commodity Channel Index (CCI) at 56.99 further confirm a -0.3 outlook for the stock.

Support, Resistance & Moving Averages From a structural perspective, NAMS is trading above its 60-day moving average of $32.694 and above its 200-day long-term moving average of $31.285. Key price levels to watch include the immediate resistance at $36.473 and strong support at $32.613. A break above $36.473 could signal a bull continuation, while falling below $32.613 may test the next Fibonacci floor at $30.812.

NewAmsterdam Pharma Company NV (NAMS) Support & Resistance Level

Name	S3	S2	S1	Pivot Points	R1	R2	R3
Classic	28.753	30.812	32.613	34.672	36.473	38.532	40.333
Fibonacci	30.812	32.286	33.197	34.672	36.146	37.057	38.532

NewAmsterdam Pharma Company NV (NAMS) Technical Indicators

2026-04-20

Name	Value
RSI_14	53.159
STOCHk_14_3_3	62.396
STOCHd_14_3_3	63.022
CCI_20	56.99
AO_5_34	2.638
MOM_10	-0.3
MACD_12_26_9	0.728

NewAmsterdam Pharma Company NV (NAMS) Relative Strength Index (RSI) is 53.159, creating a Neutral signal.

NewAmsterdam Pharma Company NV (NAMS) Stochastic Oscillator is 62.396, creating a Neutral signal.

NewAmsterdam Pharma Company NV (NAMS) Stochastic RSI is 63.022, creating a Neutral signal.

NewAmsterdam Pharma Company NV (NAMS) Commodity Channel Index (CCI) is 56.99, creating a Neutral signal.

NewAmsterdam Pharma Company NV (NAMS) Awesome Oscillator is 2.638, creating a Buy signal.

NewAmsterdam Pharma Company NV (NAMS) Momentum is -0.3, creating a Sell signal.

NewAmsterdam Pharma Company NV (NAMS) MACD is 0.728, creating a Buy signal.

NewAmsterdam Pharma Company NV (NAMS) Moving Average

2026-04-20

Period	Simple	Signal
MA_5	34.03	Sell
MA_10	34.415	Sell
MA_20	32.886	Buy
MA_60	32.694	Buy
MA_200	31.285	Buy
MA_250	28.787	Buy

NewAmsterdam Pharma Company NV (NAMS) 5-Day simple moving average is 34.03, while NewAmsterdam Pharma Company NV (NAMS) share price is $33.82, making it a Sell.

NewAmsterdam Pharma Company NV (NAMS) 10-Day simple moving average is 34.415, while NewAmsterdam Pharma Company NV (NAMS) share price is $33.82, making it a Sell.

NewAmsterdam Pharma Company NV (NAMS) 20-Day simple moving average is 32.886, while NewAmsterdam Pharma Company NV (NAMS) share price is $33.82, making it a Buy.

NewAmsterdam Pharma Company NV (NAMS) 60-Day simple moving average is 32.694, while NewAmsterdam Pharma Company NV (NAMS) share price is $33.82, making it a Buy.

NewAmsterdam Pharma Company NV (NAMS) 200-Day simple moving average is 31.285, while NewAmsterdam Pharma Company NV (NAMS) share price is $33.82, making it a Buy.

NewAmsterdam Pharma Company NV (NAMS) 250-Day simple moving average is 28.787, while NewAmsterdam Pharma Company NV (NAMS) share price is $33.82, making it a Buy.

People Also Watch

Frequently Asked Questions

What is the current technical consensus for NAMS?

The overall technical consensus for NewAmsterdam Pharma Company NV (NAMS) is currently Neutral. This rating is derived from a combined analysis of moving averages and oscillators, currently showing 3 buy signals and 4 sell signals.

What are the key support and resistance levels for NewAmsterdam Pharma Company NV (NAMS) today?

Based on pivot point calculations, NewAmsterdam Pharma Company NV (NAMS) has an immediate support level at 32.613 and a major resistance level at 36.473. Traders also monitor the pivot point at 34.672 to determine the intraday trend direction.

Is NewAmsterdam Pharma Company NV (NAMS) overbought or oversold based on the RSI?

The Relative Strength Index (RSI) for NewAmsterdam Pharma Company NV (NAMS) is currently 53.159. This indicates that the stock is in neutral territory (typically, a value below 30 is oversold and above 70 is overbought).

What signal is the MACD providing for NewAmsterdam Pharma Company NV (NAMS)?

NewAmsterdam Pharma Company NV (NAMS) Moving Averages Convergence Divergence (MACD) indicator is 0.728, suggesting NAMS is Neutral. This indicator helps identify potential trend reversals or momentum shifts for NewAmsterdam Pharma Company NV.

How is NewAmsterdam Pharma Company NV (NAMS) performing relative to its 200-day moving average?

NewAmsterdam Pharma Company NV (NAMS) is currently trading at $33.82, which is above its 200-day simple moving average of 31.285. Trading above the 200-day MA is often used by investors to determine the long-term bullish or bearish trend.